Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Sana Biotechnology Inc (NASDAQ: SANA) was $2.88 for the day, down -4.32% from the previous closing price of $3.01. In other words, the price has decreased by -$4.32 from its previous closing price. On the day, 2.58 million shares were traded.
Ratios:
Our analysis of SANA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.47 and its Current Ratio is at 4.47. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
On June 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.Rodman & Renshaw initiated its Buy rating on June 26, 2024, with a $16 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 18 ’25 when CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares for $3.16 per share.
CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares of SANA for $289,500 on Jan 16 ’25. On Jan 08 ’25, another insider, FMR LLC, who serves as The insider 1 of the company, sold 290,912 shares for $6.49 each. As a result, the insider received 1,887,320 and left with 4,541,511 shares of the company.
Stock Price History:
Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is 6.86%, while the 200-Day Moving Average is calculated to be -36.33%.
Shares Statistics:
A total of 223.11M shares are outstanding, with a floating share count of 124.25M. Insiders hold about 44.35% of the company’s shares, while institutions hold 55.97% stake in the company.
